These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 30603780)
1. Cabazitaxel inhibits prostate cancer cell growth by inhibition of androgen receptor and heat shock protein expression. Rottach AM; Ahrend H; Martin B; Walther R; Zimmermann U; Burchardt M; Stope MB World J Urol; 2019 Oct; 37(10):2137-2145. PubMed ID: 30603780 [TBL] [Abstract][Full Text] [Related]
2. Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer. Mout L; van Royen ME; de Ridder C; Stuurman D; van de Geer WS; Marques R; Buck SAJ; French PJ; van de Werken HJG; Mathijssen RHJ; de Wit R; Lolkema MP; van Weerden WM EBioMedicine; 2021 Nov; 73():103681. PubMed ID: 34749299 [TBL] [Abstract][Full Text] [Related]
3. The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells. Abazid A; Martin B; Choinowski A; McNeill RV; Brandenburg LO; Ziegler P; Zimmermann U; Burchardt M; Erb H; Stope MB J Cell Biochem; 2019 Oct; 120(10):16711-16722. PubMed ID: 31297844 [TBL] [Abstract][Full Text] [Related]
4. A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells. Naito R; Kano H; Shimada T; Makino T; Kadomoto S; Iwamoto H; Yaegashi H; Izumi K; Kadono Y; Nakata H; Saito Y; Goto M; Nakagawa-Goto K; Mizokami A Prostate; 2021 Apr; 81(5):295-306. PubMed ID: 33493355 [TBL] [Abstract][Full Text] [Related]
5. The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth. Brünnert D; Langer C; Zimmermann L; Bargou RC; Burchardt M; Chatterjee M; Stope MB J Cell Biochem; 2020 Jan; 121(1):407-417. PubMed ID: 31222811 [TBL] [Abstract][Full Text] [Related]
6. Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens. Ylitalo EB; Thysell E; Thellenberg-Karlsson C; Lundholm M; Widmark A; Bergh A; Josefsson A; Brattsand M; Wikström P Prostate; 2020 Feb; 80(2):214-224. PubMed ID: 31799745 [TBL] [Abstract][Full Text] [Related]
7. Modulation of the Prostate Cancer Resistance Factor Hsp27 by the Chemotherapeutic Drugs Abiraterone, Cabazitaxel, Docetaxel and Enzalutamide. Küster JHS; Erb HHH; Ahrend H; Abazid A; Stope MB Anticancer Res; 2024 Jul; 44(7):2815-2821. PubMed ID: 38925843 [TBL] [Abstract][Full Text] [Related]
8. Testosterone Diminishes Cabazitaxel Efficacy and Intratumoral Accumulation in a Prostate Cancer Xenograft Model. Mout L; de Wit R; Stuurman D; Verhoef E; Mathijssen R; de Ridder C; Lolkema M; van Weerden W EBioMedicine; 2018 Jan; 27():182-186. PubMed ID: 29276148 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel. Shiota M; Nakamura M; Yokomizo A; Tomoda T; Sakamoto N; Seki N; Hasegawa S; Yunoki T; Harano M; Kuroiwa K; Eto M Anticancer Res; 2020 Jan; 40(1):335-339. PubMed ID: 31892584 [TBL] [Abstract][Full Text] [Related]
10. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells. Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633 [TBL] [Abstract][Full Text] [Related]
11. Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms. Centenera MM; Carter SL; Gillis JL; Marrocco-Tallarigo DL; Grose RH; Tilley WD; Butler LM Endocr Relat Cancer; 2015 Oct; 22(5):805-18. PubMed ID: 26187127 [TBL] [Abstract][Full Text] [Related]
12. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cha TL; Qiu L; Chen CT; Wen Y; Hung MC Cancer Res; 2005 Mar; 65(6):2287-95. PubMed ID: 15781642 [TBL] [Abstract][Full Text] [Related]
13. Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27). Li J; Fu X; Cao S; Li J; Xing S; Li D; Dong Y; Cardin D; Park HW; Mauvais-Jarvis F; Zhang H J Biol Chem; 2018 Aug; 293(33):12719-12729. PubMed ID: 29934310 [TBL] [Abstract][Full Text] [Related]
14. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth. Yan J; Xie B; Capodice JL; Katz AE Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835 [TBL] [Abstract][Full Text] [Related]
15. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity. Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway. Jang YG; Go RE; Hwang KA; Choi KC J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279 [TBL] [Abstract][Full Text] [Related]
17. Artesunate Suppresses the Growth of Prostatic Cancer Cells through Inhibiting Androgen Receptor. Wang Z; Wang C; Wu Z; Xue J; Shen B; Zuo W; Wang Z; Wang SL Biol Pharm Bull; 2017; 40(4):479-485. PubMed ID: 28381803 [TBL] [Abstract][Full Text] [Related]
18. GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer. Tan SS; Ahmad I; Bennett HL; Singh L; Nixon C; Seywright M; Barnetson RJ; Edwards J; Leung HY J Pathol; 2011 Jan; 223(1):81-7. PubMed ID: 21125667 [TBL] [Abstract][Full Text] [Related]
19. Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells. Stope MB; Schubert T; Staar D; Rönnau C; Streitbörger A; Kroeger N; Kubisch C; Zimmermann U; Walther R; Burchardt M World J Urol; 2012 Jun; 30(3):327-31. PubMed ID: 22362414 [TBL] [Abstract][Full Text] [Related]
20. Shortened isoforms of the androgen receptor are regulated by the cytoprotective heat-shock protein HSPB1 and the tumor-suppressive microRNA miR-1 in prostate cancer cells. Stope MB; Bradl J; Peters S; Streitbörger A; Weiss M; Zimmermann U; Walther R; Lillig CH; Burchardt M Anticancer Res; 2013 Nov; 33(11):4921-6. PubMed ID: 24222130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]